Perella Weinberg
Perella Weinberg Partners is an independent, privately-owned financial services firm that provides corporate advisory and asset management services to clients around the world. The Firm has assembled a group of talented and experienced professionals recruited from a wide variety of leading global financial institutions.
View Older Stories View More Recent Stories
-
Avantor® to Acquire Masterflex®; Expands Proprietary Single-Use Offering for Bioproduction
-
Baxter (BAX) Acquires Hillrom (HRC) for $156/sh or $12.4B Including Debt
-
Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: Weinberg Peter A
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: Sherburne Jane Cecile
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: Shendelman Vladimir
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: OLLILA JORMA J
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: SEIDENBERG IVAN G
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: Gottschalk Alexandra
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: COHEN DANIEL G
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: Bednar Andrew
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: Becker Dietrich
-
Form 4 Perella Weinberg Partner For: Aug 31 Filed by: Barancik Gary
-
Form S-8 Perella Weinberg Partner
-
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
-
Advent International to Acquire bareMinerals, BUXOM, and Laura Mercier from Shiseido Americas
-
Virgin Orbit Confirms Deal to Merge with SPAC NextGen Acquisition Corp. II (NGCA)
-
Virgin Orbit, a Responsive Launch and Space Solutions Company, to Become Publicly Traded on Nasdaq Through a Business Combination With NextGen Acquisition Corp. II
-
Goldman Sachs Starts Perella Weinberg Partners (PWP) at Buy
-
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
-
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
-
Form 8-K Perella Weinberg Partner For: Aug 12
-
Form 424B3 Perella Weinberg Partner
-
Form 10-Q Perella Weinberg Partner For: Jun 30
-
Form 8-K Perella Weinberg Partner For: Aug 12
-
Perella Weinberg Partners Reports Second Quarter 2021 Results
-
Perella Weinberg Partners Reports Second Quarter 2021 Results
-
Form 4 Perella Weinberg Partner For: Aug 09 Filed by: COHEN DANIEL G
-
HotelPlanner, Reservations.com Enter Theee-Way Merger with SPAC Astrea Acquisition (ASAXU)
-
Form 13F-HR Perella Weinberg Partner For: Jun 30
-
Reimagining the Hotel Booking Experience: HotelPlanner and Reservations.com Enter Three-Way Merger with Astrea Acquisition Corp. to Become a Public Company Listed on NASDAQ
-
Cronos Group Reports 2021 Second Quarter Results
-
Cronos Group Reports 2021 Second Quarter Results
-
Medtronic (MDT) to Acquire Intersect ENT (XENT) for $28.25 Per Share, $1.1 Billion Deal
-
Medtronic to Acquire Intersect ENT
-
Cronos Group Inc. (CRON) Reports 2021 Second Quarter Results
-
Financial Business Services Company Pico to Merge with Betsy Cohen's SPAC in $1.75 Billion Deal
-
Betsy Cohen's SPAC to take tech firm Pico public in $1.75 billion deal
-
Exclusive: Thales poised to sell signaling unit to Hitachi for about $2 billion - source
-
CymaBay Announces $100 Million Non-Dilutive Financing with Abingworth
-
CatchMark's Triple T Joint Venture Reaches Definitive Agreement on Sale of 301,000 Acres of Prime East Texas Timberlands
-
Perella Weinberg Partners to Announce Second Quarter 2021 Financial Results and to Host Conference Call on August 12, 2021
-
Perella Weinberg Partners to Announce Second Quarter 2021 Financial Results and to Host Conference Call on August 12, 2021
-
Bioventus (BVS) Acquires Misonix (MSON) for $28/sh
-
Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix
-
Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results
-
Form EFFECT Perella Weinberg Partner
-
Form 424B3 Perella Weinberg Partner
-
Glympse Bio Appoints Matthew T. Navarro, J.D., as Chief Financial Officer
-
Form S-1 Perella Weinberg Partner

